Orlando M Gutiérrez1, Marguerite R Irvin2, Ninad S Chaudhary2, Mary Cushman3, Neil A Zakai3, Victor A David4, Sophie Limou5,6, Nathalie Pamir7, Alex P Reiner8, Rakhi P Naik9, Michele M Sale10, Monika M Safford11, Hyacinth I Hyacinth12, Suzanne E Judd13, Jeffrey B Kopp14, Cheryl A Winkler15. 1. Department of Medicine, University of Alabama at Birmingham, Birmingham, AL (O.M.G.). 2. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL (M.R.I., N.S.C.). 3. Division of Hematology and Oncology, University of Vermont, Burlington, VT (M.C., N.A.Z.). 4. Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD (V.A.D.). 5. Basic Research Laboratory, National Cancer Institute, National Institutes of Health, Leidos Biomedical Research, Frederick National Laboratory, Frederick, MD (S.L., C.A.W.). 6. Center for Research in Immunology and Transplantation, University of Nantes, Nantes, France (S.L.). 7. Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR (N.P.). 8. Department of Epidemiology, University of Washington, Seattle, WA (A.P.R.). 9. Department of Medicine, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD (R.P.N.). 10. Center for Public Health Genomics, University of Virginia, Charlottesville, VA (M.M. Sale). 11. Division of General Internal Medicine, Weill Cornell Medicine, New York, NY (M.M. Safford). 12. Department of Pediatrics, Aflac Cancer and Blood Disorder Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA (H.I.H.). 13. Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL (S.E.J.). 14. Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD (J.B.K.). winklerc@mail.nih.gov jeffreyk@intra.niddk.nih.gov. 15. Basic Research Laboratory, National Cancer Institute, National Institutes of Health, Leidos Biomedical Research, Frederick National Laboratory, Frederick, MD (S.L., C.A.W.) winklerc@mail.nih.gov jeffreyk@intra.niddk.nih.gov.
Abstract
BACKGROUND: APOL1 renal risk variants are strongly associated with chronic kidney disease in Black adults, but reported associations with cardiovascular disease (CVD) have been conflicting. METHODS: We examined associations of APOL1 with incident coronary heart disease (n=323), ischemic stroke (n=331), and the composite CVD outcome (n=500) in 10 605 Black participants of the REGARDS study (Reasons for Geographic and Racial Differences in Stroke). Primary analyses compared individuals with APOL1 high-risk genotypes to APOL1 low-risk genotypes in Cox proportional hazards models adjusted for CVD risk factors and African ancestry. RESULTS: APOL1 high-risk participants were younger and more likely to have albuminuria at baseline than APOL1 low-risk participants. The risk of incident stroke, coronary heart disease, or composite CVD end point did not significantly differ by APOL1 genotype status in multivariable models. The association of APOL1 genotype with incident composite CVD differed by diabetes mellitus status (Pinteraction=0.004). In those without diabetes mellitus, APOL1 high-risk genotypes associated with greater risk of incident composite CVD (hazard ratio, 1.67; 95% confidence interval, 1.12-2.47) compared with those with APOL1 low-risk genotypes in multivariable adjusted models. This latter association was driven by ischemic strokes (hazard ratio, 2.32; 95% confidence interval, 1.33-4.07), in particular, those related to small vessel disease (hazard ratio, 5.10; 95% confidence interval, 1.55-16.56). There was no statistically significant association of APOL1 genotypes with incident CVD in subjects with diabetes mellitus. The APOL1 high-risk genotype was associated with higher stroke risk in individuals without but not those with chronic kidney disease in fully adjusted models. CONCLUSIONS: APOL1 high-risk status is associated with CVD events in community-dwelling Black adults without diabetes mellitus.
BACKGROUND: APOL1 renal risk variants are strongly associated with chronic kidney disease in Black adults, but reported associations with cardiovascular disease (CVD) have been conflicting. METHODS: We examined associations of APOL1 with incident coronary heart disease (n=323), ischemic stroke (n=331), and the composite CVD outcome (n=500) in 10 605 Black participants of the REGARDS study (Reasons for Geographic and Racial Differences in Stroke). Primary analyses compared individuals with APOL1 high-risk genotypes to APOL1 low-risk genotypes in Cox proportional hazards models adjusted for CVD risk factors and African ancestry. RESULTS: APOL1 high-risk participants were younger and more likely to have albuminuria at baseline than APOL1 low-risk participants. The risk of incident stroke, coronary heart disease, or composite CVD end point did not significantly differ by APOL1 genotype status in multivariable models. The association of APOL1 genotype with incident composite CVD differed by diabetes mellitus status (Pinteraction=0.004). In those without diabetes mellitus, APOL1 high-risk genotypes associated with greater risk of incident composite CVD (hazard ratio, 1.67; 95% confidence interval, 1.12-2.47) compared with those with APOL1 low-risk genotypes in multivariable adjusted models. This latter association was driven by ischemic strokes (hazard ratio, 2.32; 95% confidence interval, 1.33-4.07), in particular, those related to small vessel disease (hazard ratio, 5.10; 95% confidence interval, 1.55-16.56). There was no statistically significant association of APOL1 genotypes with incident CVD in subjects with diabetes mellitus. The APOL1 high-risk genotype was associated with higher stroke risk in individuals without but not those with chronic kidney disease in fully adjusted models. CONCLUSIONS: APOL1 high-risk status is associated with CVD events in community-dwelling Black adults without diabetes mellitus.
Authors: Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak Journal: Science Date: 2010-07-15 Impact factor: 47.728
Authors: Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard Journal: Neuroepidemiology Date: 2005-06-29 Impact factor: 3.282
Authors: Lijun Ma; Carl D Langefeld; Mary E Comeau; Jason A Bonomo; Michael V Rocco; John M Burkart; Jasmin Divers; Nicholette D Palmer; Pamela J Hicks; Donald W Bowden; Janice P Lea; Jenna O Krisher; Margo J Clay; Barry I Freedman Journal: Kidney Int Date: 2016-05-06 Impact factor: 10.612
Authors: Marije van der Velde; Kunihiro Matsushita; Josef Coresh; Brad C Astor; Mark Woodward; Andrew Levey; Paul de Jong; Ron T Gansevoort; Marije van der Velde; Kunihiro Matsushita; Josef Coresh; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Ron T Gansevoort; Andrew Levey; Meguid El-Nahas; Kai-Uwe Eckardt; Bertram L Kasiske; Toshiharu Ninomiya; John Chalmers; Stephen Macmahon; Marcello Tonelli; Brenda Hemmelgarn; Frank Sacks; Gary Curhan; Allan J Collins; Suying Li; Shu-Cheng Chen; K P Hawaii Cohort; Brian J Lee; Areef Ishani; James Neaton; Ken Svendsen; Johannes F E Mann; Salim Yusuf; Koon K Teo; Peggy Gao; Robert G Nelson; William C Knowler; Henk J Bilo; Hanneke Joosten; Nanno Kleefstra; K H Groenier; Priscilla Auguste; Kasper Veldhuis; Yaping Wang; Laura Camarata; Beverly Thomas; Tom Manley Journal: Kidney Int Date: 2011-02-09 Impact factor: 10.612
Authors: Sethu M Madhavan; John F O'Toole; Martha Konieczkowski; Santhi Ganesan; Leslie A Bruggeman; John R Sedor Journal: J Am Soc Nephrol Date: 2011-10-13 Impact factor: 10.121
Authors: Kenneth J Mukamal; Joseph Tremaglio; David J Friedman; Joachim H Ix; Lewis H Kuller; Russell P Tracy; Martin R Pollak Journal: Arterioscler Thromb Vasc Biol Date: 2015-12-03 Impact factor: 8.311
Authors: Alexander T Schneider; Brett Kissela; Daniel Woo; Dawn Kleindorfer; Kathleen Alwell; Rosemary Miller; Jerzy Szaflarski; James Gebel; Jane Khoury; Rakesh Shukla; Charles Moomaw; Arthur Pancioli; Edward Jauch; Joseph Broderick Journal: Stroke Date: 2004-05-20 Impact factor: 7.914
Authors: P G Wiklund; W M Brown; T G Brott; B Stegmayr; R D Brown; S Nilsson-Ardnor; J A Hardy; B M Kissela; A Singleton; D Holmberg; S S Rich; J F Meschia Journal: Neurology Date: 2007-02-06 Impact factor: 9.910
Authors: Sophia Cameron-Christie; Charles J Wolock; Emily Groopman; Slavé Petrovski; Sitharthan Kamalakaran; Gundula Povysil; Dimitrios Vitsios; Mengqi Zhang; Jan Fleckner; Ruth E March; Sahar Gelfman; Maddalena Marasa; Yifu Li; Simone Sanna-Cherchi; Krzysztof Kiryluk; Andrew S Allen; Bengt C Fellström; Carolina Haefliger; Adam Platt; David B Goldstein; Ali G Gharavi Journal: J Am Soc Nephrol Date: 2019-05-13 Impact factor: 10.121
Authors: Alexander G Bick; Elvis Akwo; Cassianne Robinson-Cohen; Kyung Lee; Julie Lynch; Themistocles L Assimes; Scott DuVall; Todd Edwards; Huaying Fang; S Matthew Freiberg; Ayush Giri; Jennifer E Huffman; Jie Huang; Leland Hull; Rachel L Kember; Derek Klarin; Jennifer S Lee; Michael Levin; Donald R Miller; Pradeep Natarajan; Danish Saleheen; Qing Shao; Yan V Sun; Hua Tang; Otis Wilson; Kyong-Mi Chang; Kelly Cho; John Concato; J Michael Gaziano; Sekar Kathiresan; Christopher J O'Donnell; Daniel J Rader; Philip S Tsao; Peter W Wilson; Adriana M Hung; Scott M Damrauer Journal: Circulation Date: 2019-07-24 Impact factor: 29.690
Authors: Ninad S Chaudhary; Justin X Moore; Neil A Zakai; Suzanne E Judd; Rakhi P Naik; Sophie Limou; Mary Cushman; Leslie A Lange; Henry E Wang; Cheryl A Winkler; Marguerite R Irvin; Jeffrey B Kopp; Orlando M Gutiérrez Journal: Clin J Am Soc Nephrol Date: 2019-11-08 Impact factor: 8.237
Authors: Anne Cornelissen; Daniela T Fuller; Raquel Fernandez; Xiaoqing Zhao; Robert Kutys; Elizabeth Binns-Roemer; Marco Delsante; Atsushi Sakamoto; Ka Hyun Paek; Yu Sato; Rika Kawakami; Masayuki Mori; Kenji Kawai; Teruhiko Yoshida; Khun Zaw Latt; Clint L Miller; Paul S de Vries; Frank D Kolodgie; Renu Virmani; Myung Kyun Shin; Maarten Hoek; Jurgen Heymann; Jeffrey B Kopp; Avi Z Rosenberg; Harry R Davis; Liang Guo; Aloke V Finn Journal: Arterioscler Thromb Vasc Biol Date: 2021-05-27 Impact factor: 10.514
Authors: Ninad S Chaudhary; Hemant K Tiwari; Bertha A Hidalgo; Nita A Limdi; Richard J Reynolds; Mary Cushman; Neil A Zakai; Leslie Lange; Suzanne E Judd; Cheryl A Winkler; Jeffrey B Kopp; Orlando M Gutiérrez; Marguerite R Irvin Journal: Am J Nephrol Date: 2022-01-31 Impact factor: 4.605
Authors: Jung-Hwa Ryu; Mengyuan Ge; Sandra Merscher; Avi Z Rosenberg; Marco Desante; Hila Roshanravan; Koji Okamoto; Myung K Shin; Maarten Hoek; Alessia Fornoni; Jeffrey B Kopp Journal: PLoS One Date: 2019-04-18 Impact factor: 3.752
Authors: Nwamaka D Eneanya; L Ebony Boulware; Jennifer Tsai; Marino A Bruce; Chandra L Ford; Christina Harris; Leo S Morales; Michael J Ryan; Peter P Reese; Roland J Thorpe; Michelle Morse; Valencia Walker; Fatiu A Arogundade; Antonio A Lopes; Keith C Norris Journal: Nat Rev Nephrol Date: 2021-11-08 Impact factor: 42.439
Authors: Morgan E Grams; Aditya Surapaneni; Shoshana H Ballew; Lawrence J Appel; Eric Boerwinkle; L Ebony Boulware; Teresa K Chen; Josef Coresh; Mary Cushman; Jasmin Divers; Orlando M Gutiérrez; Marguerite R Irvin; Joachim H Ix; Jeffrey B Kopp; Lewis H Kuller; Carl D Langefeld; Michael S Lipkowitz; Kenneth J Mukamal; Solomon K Musani; Rakhi P Naik; Nicholas M Pajewski; Carmen A Peralta; Adrienne Tin; Christina L Wassel; James G Wilson; Cheryl A Winkler; Bessie A Young; Neil A Zakai; Barry I Freedman Journal: J Am Soc Nephrol Date: 2019-08-05 Impact factor: 14.978